FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers

An FDA panel narrowly voted 8-6 to expand access to BPC-157, an unapproved peptide popular among wellness influencers like Joe Rogan, despite FDA scientists' concerns about its safety and efficacy. The panel included industry-connected experts, and the decision is part of a broader review of seven peptides for potential compounding pharmacy use.